Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:05AM EDT. Market open.
| Previous Close | 133.66 |
| Open | 133.60 |
| Bid | 123.97 x 200 |
| Ask | 143.79 x 200 |
| Day's Range | 132.62 - 135.08 |
| 52 Week Range | 55.25 - 159.89 |
| Volume | |
| Avg. Volume | 872,303 |
| Market Cap | 12.566B |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | 309.16 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) just released its quarterly report and things are looking bullish. It was a...
- Zacks
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Insider Monkey
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript May 1, 2024 Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome […]
© 2024 Yahoo. All rights reserved.